<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04699149</url>
  </required_header>
  <id_info>
    <org_study_id>EKNZ 2019-00433</org_study_id>
    <nct_id>NCT04699149</nct_id>
  </id_info>
  <brief_title>Combining rTMS and Video Game-based Dexterity Training to Improve Dexterity in Parkinson's Disease</brief_title>
  <acronym>rTMSVR</acronym>
  <official_title>Combining rTMS and Video Game-based Dexterity Training to Improve Dexterity in Parkinson's Disease: a Randomized Controlled Pilot-study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We investigate the effectiveness of a combined repetitive transcranial magnetic stimulation&#xD;
      (rTMS) - video game-based training (VBT) dexterity intervention in Parkinson's diseases. The&#xD;
      short and long-term benefits of this training program will be evaluated. For these purposes,&#xD;
      a blinded sham controlled randomized controlled trial will be performed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with Parkinson's disease (PD) often exhibit dexterous difficulties during the&#xD;
      performance of activities of daily living (ADL) such as tying shoe laces, hand-writing, using&#xD;
      remote controls, smartphone or tablet. These difficulties further add to the burden of the&#xD;
      disease, leading to reduced quality of life (QoL). A relatively new, but rapidly growing&#xD;
      aspect of training in PD neurorehabilitation is exergaming. To enhance training effects a&#xD;
      combination of repetitive transcranial magnetic stimulation (rTMS) with exergaming will be&#xD;
      tested.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 11, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>blinded randomised clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>rTMS protocol either sham or real</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>DextQ-24</measure>
    <time_frame>3 weeks</time_frame>
    <description>standardized patient self-rated outcome measure (PROM) for evaluating dexterity related ADL in PD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nine Hole Peg test (9-HPT)</measure>
    <time_frame>3 weeks</time_frame>
    <description>The 9-HPT is a standardized, well established, and reliable measure of hand dexterity in patients with PD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coin rotation task (CRT)</measure>
    <time_frame>3 weeks</time_frame>
    <description>The CRT measures fine coordinated finger movements and is a suitable and valid dexterity test in patients with PD.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>real stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The PD patients randomized in the experimental group will receive VBT each time preceded by a real rTMS stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The PD patients randomized in the control group will receive VBT each time preceded by a sham TMS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transcranial magnetic stimulation</intervention_name>
    <description>Non-invasive brain stimulation</description>
    <arm_group_label>real stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham transcranial magnetic stimulation</intervention_name>
    <description>Non-invasive brain stimulation</description>
    <arm_group_label>sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Confirmed PD&#xD;
&#xD;
          2. Hoehn &amp; Yahr I to IV&#xD;
&#xD;
          3. Age 50-80 years old&#xD;
&#xD;
          4. written and signed informed consent&#xD;
&#xD;
          5. dexterous difficulties-&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Significant medical, psychiatric co-morbidity including dementia as defined by&#xD;
             Montreal Cognitive Assessment (MOCA &lt; 21)&#xD;
&#xD;
          2. Inability to understand the scope of the study and to follow study procedures&#xD;
             according to the protocol e.g. complete questionnaires (i.e. due to cognitive&#xD;
             problems)&#xD;
&#xD;
          3. Exclusion criteria for TMS and Sham application, such as current pregnancy, personal&#xD;
             history of epilepsy or epileptic fits, and any psychiatric, neurologic, or medical&#xD;
             history.&#xD;
&#xD;
          4. Participation in another interventional trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tim Vanbellingen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Luzerner Kantonsspital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manuela Pastore-Wapp</last_name>
    <phone>+41 41 205 7220</phone>
    <email>manuela.pastore@luks.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Luzerner Kantonsspital</name>
      <address>
        <city>Lucerne</city>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuela Pastore-Wapp, PhD</last_name>
      <phone>041 205 72 20</phone>
      <email>manuela.pastore@luks.ch</email>
    </contact>
    <investigator>
      <last_name>Tim Vanbellingen, PD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transcranial magnetic stimulation</keyword>
  <keyword>dexterity</keyword>
  <keyword>video game-based training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

